CME Group Proxy Statement Filed

TL;DR

CME Group filed its proxy statement for 2024, shareholders get to vote.

AI Summary

CME Group Inc. filed a Definitive Proxy Statement (DEFA14A) on March 21, 2024, detailing its 2024 Class B campaign letters. The filing includes information related to the company's proxy materials and is part of its ongoing corporate communications.

Why It Matters

This filing provides shareholders with essential information regarding the company's governance and voting matters, allowing them to make informed decisions.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain information that suggests immediate financial risk.

Key Players & Entities

• CME GROUP INC. (company) — Registrant
• Will Hobert (person) — Candidate mentioned in the filing
• 20 S. WACKER DR. (company) — Business and Mail Address

FAQ

Filing Documents

• a2024classbcampaignletters.htm (DEFA14A) — 35KB
• classbletterscombined_20001.jpg (GRAPHIC) — 280KB
• classbletterscombined_20002.jpg (GRAPHIC) — 103KB
• classbletterscombined_20003.jpg (GRAPHIC) — 212KB
• classbletterscombined_20004.jpg (GRAPHIC) — 101KB
• classbletterscombined_20005.jpg (GRAPHIC) — 242KB
• classbletterscombined_20006.jpg (GRAPHIC) — 102KB
• classbletterscombined_20007.jpg (GRAPHIC) — 231KB
• classbletterscombined_20008.jpg (GRAPHIC) — 111KB
• classbletterscombined_20009.jpg (GRAPHIC) — 201KB
• classbletterscombined_20010.jpg (GRAPHIC) — 103KB
• classbletterscombined_20011.jpg (GRAPHIC) — 252KB
• classbletterscombined_20012.jpg (GRAPHIC) — 102KB
• coverpageforadef14a001.jpg (GRAPHIC) — 92KB
• 0001156375-24-000061.txt ( ) — 2973KB

From the Filing

2024 Class B Campaign Letters UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Under §240.14a-12 CME GROUP INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 Hello, My name is Will Hobert and I am a candidate for a Class B-1 seat on the CME Group Board of Directors. I was first elected to the CME Group Board in 2015. Currently, I co-chair the Clearing House Risk Committee (CHRC) and Chair the Interest Rate Swap Risk Committee (IRSRC). I am also a member of the Clearing House Oversight Committee (CHOC). I am running on my three decades of industry experience as an open outcry market maker, electronic options and futures trader, company founder, and owner of WH Trading. As managing Member of WH Trading, I oversee technology, risk management, operations and strategy development. Since founding WH Trading in 1994, the firm has grown to over 80 employees. WH Trading participates in a wide range of futures and options markets, both on the CME Group floor and electronically on numerous exchanges worldwide. Like many market participants, we have developed in-house proprietary options and futures trading software and we benchmark the performance of our trading systems at the microsecond level. I am running on my ability to adapt to changes in a dynamic trading industry and my resultant success as a proprietary firm owner. Over the last two decades, CME Group has grown and advanced as technology has driven massive change in the trading industry and capital markets. Similarly, WH Trading has reinvented itself to adapt to the new trading landscape. As financial markets evolved and liquidity shifted from open outcry to the electronic trading screens, WH Trading, like CME Group, was forced to make the challenging transition from a trading firm to a technology firm. Over the last two decades, I have guided WH Trading through a major expansion as we built an electronic, automated trading operation that has also served to enhance and grow our robust floor trading operation. However, the advancement of technology and the evolution of the financial markets is a never-ending process and in the coming decade one's ability to adapt to changes, some of which we cannot currently predict, will dictate survival and success. I know what it takes to survive and thrive amidst change, and as a CME Group Board member, I will tirelessly work to ensure that the Exchange and its members are best prepared for the next systemic change. I am running because the Board of Directors needs a member who has a diverse trading background that includes open outcry, electronic, over the counter and options trading experience. I have traded on all of these execution venues and understand the issues, benefits and market structure implications associated with each. With options trading approaching 20% of CME Group's overall volume in 2022, its members deserve a Board member who truly understands the critical issues, complex market structure and pressing problems facing options traders. My 30+ years of option trading, risk management, and strategic planning would provide a necessary voice on the Board of Directors as open outcry, exchange matching engines and voice brokers all compete for options volume. Finally, WH Trading holds memberships at CME, CBOT, NYMEX, and COMEX which has provided me with a holistic perspective of CME Group and the unique challenges and opportunities that face CME members. I am running because I understand the importance of strong advocacy with elected officials. Over the past two decades, I have worked to advocate on behalf of and preserve the interests of the trading industry. Annually, I travel to Washington, DC to advocate on behalf of CME Group where I have participated in informational sessions with SEC and CFTC commissioners, House and Senate Committees, and Congressional Leadership. I have participated in a small intimate meeting with House leadership with the goal of representing CME Group's interests and legislative priorities. I understand the importance of strong relationships with Washington, DC. As a result, I was solicited to serve as a CME PAC Board of Director working to ensure that support is given to candidates, regardless of political affiliation, to ensure their education and understanding of CME Group. Sho

View Full Filing

View this DEFA14A filing on SEC EDGAR